Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.
about
The notch ligand JAGGED1 as a target for anti-tumor therapyMelanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator functionNotch signaling and T-helper cells in EAE/MSInactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1Emerging molecular targets for the treatment of pre-eclampsia.Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.Notch regulation of lymphocyte development and function.Notch system in the linkage of innate and adaptive immunity.Notch: a unique therapeutic target for immunomodulation.Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes.CD4+ regulatory cells as a potential immunotherapy.Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.Emerging possibilities in the development and function of regulatory T cells.Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation.Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cellsNotch1 signaling is involved in regulating Foxp3 expression in T-ALL.Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trendsNotch signaling in the hematopoietic system.EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.Targeting the Notch Pathway to Prevent Rejection.Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.Notch Signaling and Alloreactivity.Overexpression of Jagged-1 combined with blockade of CD40 pathway prolongs allograft survival.The deposition of Notch1 in hepatitis B virus-associated nephropathy and its role in hepatitis B virus X protein-induced epithelial-mesenchymal transdifferentiation and immunity disorder in renal tubular epithelial cells.Notch Signaling in T Helper Cell Subsets: Instructor or Unbiased Amplifier?TNF and Bone Remodeling.Spectrum of T-lymphocyte activities regulating allergic lung inflammation.OX40L/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells.BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling.Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infection.Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.Mouse Sertoli cells sustain de novo generation of regulatory T cells by triggering the notch pathway through soluble JAGGED1.Notch activation on effector T cells increases their sensitivity to Treg cell-mediated suppression through upregulation of TGF-βRII expression.FOXP3 knockdown inhibits the proliferation and reduces NOTCH1 expression of T cell acute lymphoblastic leukemia cells
P2860
Q21129294-584D90FC-24C9-44DF-A139-96483196DEE5Q24614044-D655E91E-D8E4-4088-8CDF-909AE05F2BF6Q27002542-21020558-5510-41D7-8DD6-6F9B7D14804DQ33419208-680368E3-953E-4FCD-AF1C-749BDA50B7CFQ35046775-51FA4377-FA8C-48CF-A84D-8A5EC78A87E5Q35050406-7C3BAB83-5141-480C-B15D-E2F1D717DEF0Q35164666-7217B0FA-A32E-4A1B-BD4F-976691103BCCQ35676281-68B3168E-98A2-4B7D-9271-05C9BF5CE873Q36055999-01F74B72-9C23-4EA2-B9CE-506125009409Q36150879-E372A87A-CDCC-4453-A013-08CF8D6AD3E8Q36245673-CCCCAFCB-88D0-4E48-9E2E-8A9F921174C7Q36251271-D0FD9421-CCD6-4E2E-8889-E450CBA8D590Q36296504-8E578F9E-F9C5-4156-AA87-AD56C90C01C1Q36486882-94550514-90F9-4522-9FC8-393B20AF2CCBQ36639992-DE5D11E7-415A-468F-88CD-940EBA295D00Q36843721-0504B8E1-2826-4338-B3E1-636A5899C0B5Q36874225-9F3DFC90-635D-447E-A423-BA93B21F2EB8Q36955660-25F1A1F7-3B6A-4201-BE0C-CA14C39E158FQ37594765-34E23E8A-F6F9-4673-9468-B81D11BF34ADQ38309146-13ABC39A-A593-4828-B336-26F7C0F2CB7EQ38796193-B587239E-4550-44F5-85A5-7F49E64B2CADQ38803570-9CEDF5C7-4D0A-470A-B97C-225383FC373AQ38949407-5911E97C-C0C4-4C88-B75D-65A815AEE971Q38950168-D70B0322-54CC-40E4-A872-60FC16C66BA7Q39015607-4505A08C-4E1D-408C-9F17-35974EF5AFFDQ39274325-A98A8CDE-2853-4C11-8DEC-FE7D43619C17Q39287117-0E7F29B8-617B-40F1-B072-BFBF9717F314Q39402895-E74C9F92-2993-4D0A-BFA0-7D5495776B36Q40906691-43FC4D8D-82C5-45EE-885A-49CF3FD565E6Q43238483-99B816F2-ADDE-4FD3-AA1B-498471937153Q50868404-64EC268E-B1C8-4F25-8AA4-74D8B46EF0A7Q51369795-D7108F22-D626-45EF-87B1-A8B96C6C4C7FQ53069060-64B904E7-4C98-48AA-A899-67849E65E61FQ54309935-4315F047-5CDB-415B-BFC0-9CDCBF44DEF9Q58786605-5D33A148-DF96-46BD-BE15-20454A2D5EF5
P2860
Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Induction of antigen-specific ...... ligand by human B lymphocytes.
@en
Induction of antigen-specific ...... ligand by human B lymphocytes.
@nl
type
label
Induction of antigen-specific ...... ligand by human B lymphocytes.
@en
Induction of antigen-specific ...... ligand by human B lymphocytes.
@nl
prefLabel
Induction of antigen-specific ...... ligand by human B lymphocytes.
@en
Induction of antigen-specific ...... ligand by human B lymphocytes.
@nl
P2093
P2860
P1433
P1476
Induction of antigen-specific ...... ligand by human B lymphocytes.
@en
P2093
Cecilia Lira
Cliona M Rooney
Ettore Biagi
Gianpietro Dotti
Hans-Joachim Wagner
Malcolm K Brenner
Stéphane Vigouroux
Uluhan Sili
P2860
P304
10872-10880
P356
10.1128/JVI.77.20.10872-10880.2003
P407
P577
2003-10-01T00:00:00Z